Becton, Dickinson and Company (NYSE:BDX) Price Target Raised to $279.00
Becton, Dickinson and Company (NYSE:BDX – Get Free Report) had its price target lifted by equities research analysts at Barclays from $278.00 to $279.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has an “overweight” rating on the medical instruments supplier’s stock. Barclays‘s price objective would suggest a potential upside […]
Becton, Dickinson and Company (NYSE:BDX – Get Free Report) had its price target lifted by equities research analysts at Barclays from $278.00 to $279.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has an “overweight” rating on the medical instruments supplier’s stock. Barclays‘s price objective would suggest a potential upside […]
